What we do
Biostache is a service dedicated to providing articles, updates and newsletters relating to biotech news.
Featured
Recently, I had the chance to sit down and chat with ResearchSat’s founder/CEO RaviTeja Duggineni and their head of investor relations, Rahul Kundnani.
Last year, Mesoblast Ltd had their therapeutic RYONCIL approved by the FDA. This article touches on the journey to get to this milestone.
Heart disease remains one of the leading causes of death globally, BiVACOR may be the solution to this – a total artificial heart that utilises a single motor with MAGLEV technology to pump blood to the lungs and body.
Antibiotics are arguably one of the most important biotechnological inventions of the last century. Access to effective antibiotic and antimicrobial drugs has saved countless lives, and allowed for advancements in healthcare, increasing the success of other medical interventions such as surgery and chemotherapy.
NewsLetter
